288 related articles for article (PubMed ID: 19182698)
21. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
Stovall DW; Pinkerton JV
Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
[TBL] [Abstract][Full Text] [Related]
22. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
Kwee SH; Tan HH; Marsman A; Wauters C
Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
24. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
25. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms.
Kaszkin-Bettag M; Ventskovskiy BM; Solskyy S; Beck S; Hasper I; Kravchenko A; Rettenberger R; Richardson A; Heger PW
Altern Ther Health Med; 2009; 15(1):24-34. PubMed ID: 19161045
[TBL] [Abstract][Full Text] [Related]
26. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
Pinkerton JV; Utian WH; Constantine GD; Olivier S; Pickar JH
Menopause; 2009; 16(6):1116-24. PubMed ID: 19546826
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
Archer DF;
Menopause; 2003; 10(6):516-21. PubMed ID: 14627859
[TBL] [Abstract][Full Text] [Related]
28. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts.
Heyerick A; Vervarcke S; Depypere H; Bracke M; De Keukeleire D
Maturitas; 2006 May; 54(2):164-75. PubMed ID: 16321485
[TBL] [Abstract][Full Text] [Related]
29. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement.
Campagnoli C; Abbà C; Ambroggio S; Peris C; Perona M; Sanseverino P
Maturitas; 2005 Jun; 51(2):127-34. PubMed ID: 15917152
[TBL] [Abstract][Full Text] [Related]
30. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms.
Ferrari A
J Obstet Gynaecol Res; 2009 Dec; 35(6):1083-90. PubMed ID: 20025635
[TBL] [Abstract][Full Text] [Related]
31. The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
Stovall DW; Utian WH; Gass ML; Qu Y; Muram D; Wong M; Plouffe L
Menopause; 2007; 14(3 Pt 1):510-7. PubMed ID: 17314736
[TBL] [Abstract][Full Text] [Related]
32. Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
Yu H; Racketa J; Chines AA; Mirkin S
Climacteric; 2013 Apr; 16(2):252-7. PubMed ID: 23035721
[TBL] [Abstract][Full Text] [Related]
33. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Landgren MB; Helmond FA; Engelen S
Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
[TBL] [Abstract][Full Text] [Related]
34. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Pinkerton JV; Pickar JH; Racketa J; Mirkin S
Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
[TBL] [Abstract][Full Text] [Related]
35. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies.
Zaborowska E; Brynhildsen J; Damberg S; Fredriksson M; Lindh-Astrand L; Nedstrand E; Wyon Y; Hammar M
Climacteric; 2007 Feb; 10(1):38-45. PubMed ID: 17364603
[TBL] [Abstract][Full Text] [Related]
36. Identifying meaningful differences in vasomotor symptoms among menopausal women.
Wyrwich KW; Spratt DI; Gass M; Yu H; Bobula JD
Menopause; 2008; 15(4 Pt 1):698-705. PubMed ID: 18369313
[TBL] [Abstract][Full Text] [Related]
37. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial.
Heger M; Ventskovskiy BM; Borzenko I; Kneis KC; Rettenberger R; Kaszkin-Bettag M; Heger PW
Menopause; 2006; 13(5):744-59. PubMed ID: 16894335
[TBL] [Abstract][Full Text] [Related]
39. Soy extracts versus hormone therapy for reduction of menopausal hot flushes: indirect comparison.
Bolaños-Díaz R; Zavala-Gonzales JC; Mezones-Holguín E; Francia-Romero J
Menopause; 2011 Jul; 18(7):825-9. PubMed ID: 21358349
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
